FDA Halts Two Gene Therapy Trials After Child Develops Brain Tumor

(MedPage Today) — The FDA halted studies of two investigational gene therapies for rare pediatric diseases after a child treated in a clinical trial developed a brain tumor, RegenxBio said Wednesday.
The holds affect RGX-111 and RGX-121, therapies…

Source link : https://www.medpagetoday.com/neurology/generalneurology/119638

Author :

Publish date : 2026-01-29 14:12:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

FDA Halts Two Gene Therapy Trials After Child Develops Brain Tumor

Norovirus Fills More Beds as Flu Pressure Recedes

‘Night Owls’ and Heart Risks; AI Grades Med School Exams; GLP-1 Drug Patients Sue

Related Posts

New Videos Show Alex Pretti Scuffle With Federal Officers 11 Days Before His Death

FDA OKs More Eye Drops That Can Replace Reading Glasses

U.S. Life Expectancy Hit an All-Time High in 2024, CDC Says

Overdose Risk as Quetiapine Supplied at Double Strength

Weight loss jab users warned over rare but serious pancreas issue

Nurse Fired Over Social Media Posts; Biotech CEO Gets 30 Months in Prison

New Videos Show Alex Pretti Scuffle With Federal Officers 11 Days Before His Death

FDA OKs More Eye Drops That Can Replace Reading Glasses

U.S. Life Expectancy Hit an All-Time High in 2024, CDC Says

Overdose Risk as Quetiapine Supplied at Double Strength

Weight loss jab users warned over rare but serious pancreas issue

Nurse Fired Over Social Media Posts; Biotech CEO Gets 30 Months in Prison

Fellow Nurses: What Do You Call a Nursing Home Without a Nurse?

Polar bears are getting fatter in the fastest-warming place on Earth

Categories

Archives